BETA

4 Amendments of Franc BOGOVIČ related to 2021/2013(INI)

Amendment 143 #
Draft opinion
Paragraph 3 a (new)
3 a. Calls on the Commission to propose solutions that promote health systems fiscal sustainability, such as increasing the share of resources within healthcare budgets allocated for investments in prevention and strengthening primary care systems; and stresses the importance of promoting the sustainability of the pharmaceutical supply chain, including by adequately remunerating community pharmacists for the services they provide;
2021/06/02
Committee: ITRE
Amendment 150 #
Draft opinion
Paragraph 3 b (new)
3 b. Calls on Member States to encourage the uptake of generics and biosimilars in the EU by introducing financial incentives to healthcare professionals such as pharmacists to dispense these products to patients;
2021/06/02
Committee: ITRE
Amendment 164 #
Draft opinion
Paragraph 4 a (new)
4 a. Recommends that a key requirement for a Pharmaceutical Strategy for Europe should be that the flow of medicines meets patients demands and is not based on pure commercial interests; recommends the establishment of further EU guidance to Member States on the import and export of medicines across borders;
2021/06/02
Committee: ITRE
Amendment 213 #
Draft opinion
Paragraph 7 a (new)
7 a. Calls the Commission and Member States to encourage cross- country cooperation to promote joint negotiations on the pricing of medicines and/or joint health technology assessments (HTAs);
2021/06/02
Committee: ITRE